Used as an intermediate in the synthesis of nitroimidazole-based pharmaceuticals, particularly in the development of antimicrobial and antiparasitic agents. Its structure supports the creation of bioactive molecules that target anaerobic bacteria and certain protozoan infections. Commonly employed in medicinal chemistry for modifying pharmacokinetic properties of imidazole derivatives. Also utilized in research settings to develop new compounds with potential therapeutic activity.